Cardihab CEO Helen Souris joined Dr Ross Walker on the Healthy Living Show to speak about the new clinical study published in JMIR Publications;

A clinical study of patients with cardiovascular disease by Queensland Cardiovascular Group has found that offering a digital health platform,…

Our inspiration and motivation comes from the people whose lives we help change. We all hoped we would be rejoicing…

Australia’s only not-for-profit digital health commercialisation organisation, ANDHealth today announced that Cardihab has been selected to take part in its Medical Research Future Fund (MRFF) funded ANDHealth+ program.

Australian digital health startup Cardihab is changing the lives of thousands of people with cardiac disease – the world’s biggest killer.

Digital health is bringing new solutions that are transforming the lives of thousands of people with cardiac disease.

In October 2021, AstraZeneca and Slush joined forces with a few start-ups and entrepreneurs for a collaborative event providing a…

Countless new health tech innovations may have popped up over the past two years, but has it been enough to overcome hesitancy toward telehealth.

Today the Baker Heart and Diabetes Institute announced a world leading investigation into the long-term heart damage caused by COVID-19.

We are delighted to have the ImpaQT Group’s support and investment to help us to fulfil our mission of improving access to care for patients recovering from cardiac events and/or living with heart disease.

Digital health will take transformative steps by supporting new clinical trials to address secondary prevention of Australia’s deadliest disease following an agreement between Australian digital health company Cardihab and medical research organisation, the Baker Heart and Diabetes Institute.

Read how Cardihab and Baker Heart and Diabetes Institute, a medical research organisation in Melbourne, have signed a five-year agreement to jointly conduct clinical trials and cohort studies.